User menu

Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study.

Bibliographic reference Libert, Yves ; Borghgraef, Cindy ; Beguin, Yves ; Delvaux, Nicole ; Devos, Martine ; et. al. Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study.. In: Psycho-Oncology : journal of the psychological, social and behavioral dimensions of cancer, (2017)
Permanent URL http://hdl.handle.net/2078.1/183783
  1. Butler Karin M., Mcdaniel Mark A., Dornburg Courtney C., Price Amanda L., Roediger Henry L., Age differences in veridical and false recall are not inevitable: The role of frontal lobe function, 10.3758/bf03196722
  2. Wefel Jeffrey S., Lenzi Renato, Theriault Richard L., Davis Robert N., Meyers Christina A., The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma : Results of a prospective, randomized, longitudinal trial, 10.1002/cncr.20272
  3. van Dam Frits S. A. M., Boogerd Willem, Schagen Sanne B., Muller Martin J., Droogleever Fortuyn Maria E., Wall Elsken v.d., Rodenhuis Sjoerd, Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy, 10.1093/jnci/90.3.210
  4. Maccormick Ronald Eric, Possible acceleration of aging by adjuvant chemotherapy: A cause of early onset frailty?, 10.1016/j.mehy.2006.01.045
  5. Ahles Tim A., Saykin Andrew J., Candidate mechanisms for chemotherapy-induced cognitive changes, 10.1038/nrc2073
  6. Jenkins Valerie, Shilling Valerie, Fallowfield Lesley, Howell Anthony, Hutton Sam, Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study, 10.1002/pon.709
  7. Koppelmans Vincent, Breteler Monique M.B., Boogerd Willem, Seynaeve Caroline, Gundy Chad, Schagen Sanne B., Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy, 10.1200/jco.2011.37.0189
  8. KVALE E.A., CLAY O.J., ROSS-MEADOWS L.A., MCGEE J.S., EDWARDS J.D., UNVERZAGT F.W., RITCHIE C.S., BALL K.K., Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial, 10.1111/j.1365-2354.2008.01018.x
  9. Yamada Torricia H., Denburg Natalie L., Beglinger Leigh J., Schultz Susan K., Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy, 10.1176/jnp.2010.22.1.48
  10. Mohile Supriya Gupta, Lacy Maureen, Rodin Miriam, Bylow Kathryn, Dale William, Meager Michael R., Stadler Walter M., Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer, 10.1016/j.critrevonc.2010.06.009
  11. Hurria Arti, Goldfarb Shari, Rosen Carol, Holland Jimmie, Zuckerman Enid, Lachs Mark S., Witmer Matthew, van Gorp Wilfred G., Fornier Monica, D’Andrea Gabriella, Moasser Mark, Dang Chau, Van Poznak Catherine, Robson Mark, Currie Violante E., Theodoulou Maria, Norton Larry, Hudis Clifford, Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective, 10.1007/s10549-006-9171-6
  12. Extermann M, A comprehensive geriatric intervention detects multiple problems in older breast cancer patients, 10.1016/s1040-8428(03)00099-4
  13. Chen Hongbin, Cantor Alan, Meyer Julie, Beth Corcoran Mary, Grendys Edward, Cavanaugh Denise, Antonek Shirley, Camarata Angela, Haley William, Balducci Lodovico, Extermann Martine, Can older cancer patients tolerate chemotherapy? : A prospective pilot study, 10.1002/cncr.11110
  14. BUCKWALTER J. GALEN, CROOKS VALERIE C., PETITTI DIANA B., COGNITIVE PERFORMANCE OF OLDER WOMEN WHO HAVE SURVIVED CANCER, 10.1080/00207450590934534
  15. Ferguson Robert J., McDonald Brenna C., Saykin Andrew J., Ahles Tim A., Brain Structure and Function Differences in Monozygotic Twins: Possible Effects of Breast Cancer Chemotherapy, 10.1200/jco.2007.10.8639
  16. Schrijnemaekers A.M.C., de Jager Celeste A., Hogervorst E., Budge M.M., Cases with Mild Cognitive Impairment and Alzheimer’s Disease Fail to Benefit from Repeated Exposure to Episodic Memory Tests as Compared with Controls, 10.1080/13803390590935462
  17. Posner, Cognitive Psychology: Key Readings, 205 (2004)
  18. Arndt Jamie, Das Enny, Schagen Sanne B., Reid-Arndt Stephanie A., Cameron Linda D., Ahles Tim A., Broadening the cancer and cognition landscape: the role of self-regulatory challenges : Self-regulation, cancer, and cognition, 10.1002/pon.3351
  19. Suchy Yana, Kraybill Matthew L., Franchow Emilie, Practice Effect and Beyond: Reaction to Novelty as an Independent Predictor of Cognitive Decline Among Older Adults, 10.1017/s135561771000130x
  20. Katz Sidney, Studies of Illness in the Aged : The Index of ADL: A Standardized Measure of Biological and Psychosocial Function, 10.1001/jama.1963.03060120024016
  21. Roehrig Bernd, Hoeffken Klaus, Pientka Ludger, Wedding Ulrich, How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening, 10.1016/j.critrevonc.2006.10.001
  22. Wechsler, Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) (2008)
  23. Grober Ellen, Buschke Herman, Genuine memory deficits in dementia, 10.1080/87565648709540361
  24. Reitan Ralph M., Validity of the Trail Making Test as an Indicator of Organic Brain Damage, 10.2466/pms.1958.8.3.271
  25. Joly F., Lange M., Rigal O., Correia H., Giffard B., Beaumont J. L., Clisant S., Wagner L., French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) version 3, 10.1007/s00520-012-1439-2
  26. Wagner, J Support Oncol, 7, W32 (2009)
  27. Zigmond A. S., Snaith R. P., The Hospital Anxiety and Depression Scale, 10.1111/j.1600-0447.1983.tb09716.x
  28. Williams Annalynn M., Zent Clive S., Janelsins Michelle C., What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research, 10.1111/bjh.14211
  29. Asher, Clin Adv Hematol Oncol, 13, 441 (2015)